Abstract:MicroRNA-454 (miR-454) is emerging as critical regulator in tumorigenesis; it may function as an oncogene or a tumor suppressor. However, the role of miR-454 in prostate cancer remains unknown. In this study, we aimed to investigate the function and molecular mechanisms of miR-454 in prostate cancer. We found that miR-454 was highly expressed in prostate cancer tissues and cell lines (*p<0.05), as detected by real-time quantitative polymerase chain reaction (RT-qPCR). Cell counting kit-8 assay, colony formation assay and cell invasion assay showed that the inhibition of miR-454 significantly suppressed prostate cancer cell proliferation and invasion (*p<0.05), whereas the overexpression of miR-454 markedly promoted prostate cancer cell proliferation and invasion (*p<0.05). Bioinformatics analysis showed that N-myc downstream-regulated gene 2 (NDRG2), a well-known tumor suppressor, was identified as a potential target gene of miR-454. Dual-luciferase reporter assay showed that miR-454 directly targeted the 3′-untranslated region of NDRG2. RT-qPCR and western blot showed that miR-454 overexpression significantly decreased NDRG2 expression (*p<0.05), whereas miR-454 inhibition markedly promoted NDRG2 expression (*p<0.05). Spearman’s correlation analysis showed that miR-454 expression was inversely correlated with NDRG2 expression in prostate cancer tissues (r=−0.8932; p<0.0001). Moreover, miR-454 inhibition significantly suppressed the protein expression of β-catenin (*p<0.05) and blocked the activation of WNT signaling (*p<0.05). In addition, small interfering RNA mediated NDRG2 knockdown significantly reversed the antitumor effect of miR-454 inhibition on prostate cancer cell proliferation and invasion (*p<0.05). Taken together, these results reveal an oncogenic role of miR-454, which promotes prostate cancer cell proliferation and invasion by downregulation of NDRG2. These results also suggest miR-454 as a potential therapeutic target for the treatment of prostate cancer.

Mir-3619-5p Inhibits Prostate Cancer Cell Growth by Activating CDKN1A Expression.

Nonconserved Mir‐608 Suppresses Prostate Cancer Progression Through RAC2/PAK4/LIMK1 and BCL2L1/caspase‐3 Pathways by Targeting the 3′‐utrs of RAC2/BCL2L1 and the Coding Region of PAK4

Mir-181a-5p Is Downregulated And Inhibits Proliferation And The Cell Cycle In Prostate Cancer

MicroRNA-107 Inhibits Proliferation of Prostate Cancer Cells by Targeting Cyclin E1.

MicroRNA-193a-3p Inhibits Cell Proliferation in Prostate Cancer by Targeting Cyclin D1

Mirna-30A Functions As a Tumor Suppressor by Downregulating Cyclin E2 Expression in Castration-Resistant Prostate Cancer.

MicroRNA-302a Suppresses Tumor Cell Proliferation by Inhibiting AKT in Prostate Cancer.

Mir-5100 Overexpression Inhibits Prostate Cancer Progression by Inducing Cell Cycle Arrest and Targeting E2F7

Suppression of Microrna-454 Impedes the Proliferation and Invasion of Prostate Cancer Cells by Promoting N-myc Downstream-Regulated Gene 2 and Inhibiting WNT/β-catenin Signaling

Effects of Mir-361-5p on Proliferation and Invasion in Androgen-Independent Human Prostate Cancer Cell Line PC3

Mir199b Suppresses Expression Of Hypoxia-Inducible Factor 1 Alpha (Hif-1 Alpha) In Prostate Cancer Cells

455-3p is markedly downregulated in prostate cancer cell lines and clinical tumor specimens. Gain-of-function and loss-of- function studies showed that miR-455-3p promotes prostate cancer cell growth both in vitro and in vivo. Bioinformatics analysis and Luciferase reporter assays demonstrated that

miR-31-5p Regulates 14-3-3 ɛ to Inhibit Prostate Cancer 22RV1 Cell Survival and Proliferation via PI3K/AKT/Bcl-2 Signaling Pathway.

Mir-20B Promotes Cellular Proliferation and Migration by Directly Regulating Phosphatase and Tensin Homolog in Prostate Cancer.

Mir-141 Inhibits Prostatic Cancer Cell Proliferation and Migration, and Induces Cell Apoptosis Via Targeting of RUNX1

Downregulation of Mirna-205 Expression and Biological Mechanism in Prostate Cancer Tumorigenesis and Bone Metastasis.

Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5E.

MicroRNA-340 Inhibits Prostate Cancer Cell Proliferation and Metastasis by Targeting the MDM2-p53 Pathway.

miR-200b suppresses cell proliferation, migration and enhances chemosensitivity in prostate cancer by regulating Bmi-1.

Mir-326 Functions As a Tumor Suppressor in Human Prostatic Carcinoma by Targeting Mucin1

MiR-182 Promotes Prostate Cancer Progression Through Activating Wnt/β-catenin Signal Pathway